304 related articles for article (PubMed ID: 22775520)
21. Pharmaceutical care research and education project: pharmacists' interventions.
Kassam R; Farris KB; Burback L; Volume CI; Cox CE; Cave A
J Am Pharm Assoc (Wash); 2001; 41(3):401-10. PubMed ID: 11372905
[TBL] [Abstract][Full Text] [Related]
22. Classification of drug-related problems with new prescriptions using a modified PCNE classification system.
Eichenberger PM; Lampert ML; Kahmann IV; van Mil JW; Hersberger KE
Pharm World Sci; 2010 Jun; 32(3):362-72. PubMed ID: 20229029
[TBL] [Abstract][Full Text] [Related]
23. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
Blake KB; Madhavan SS
Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
[TBL] [Abstract][Full Text] [Related]
24. Audit of community pharmacists' prescribing interventions: Quality assessment of a newly reimbursed service.
MacKeigan LD; Dolovich L; Petrovic B; MacCallum L; Bojarski EA; Pojskic N
J Am Pharm Assoc (2003); 2018; 58(6):622-629. PubMed ID: 30190200
[TBL] [Abstract][Full Text] [Related]
25. Validation of a tool for reporting pharmacists' interventions in everyday community pharmacy.
Vo TH; Bardet JD; Charpiat B; Leyrissoux C; Gravoulet J; Allenet B; Conort O; Bedouch P
J Clin Pharm Ther; 2018 Apr; 43(2):240-248. PubMed ID: 29143347
[TBL] [Abstract][Full Text] [Related]
26. The decision-making processes of pharmacists in inland Australia--a pilot study.
Madden ME; Ball PA
Rural Remote Health; 2011; 11(2):1573. PubMed ID: 21534711
[TBL] [Abstract][Full Text] [Related]
27. Strengthening pharmacy practice in vietnam: findings of a training intervention study.
Minh PD; Huong DT; Byrkit R; Murray M
Trop Med Int Health; 2013 Apr; 18(4):426-34. PubMed ID: 23294473
[TBL] [Abstract][Full Text] [Related]
28. Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study.
Bereznicki B; Peterson G; Jackson S; Haydn Walters E; DeBoos I; Hintz P
J Clin Pharm Ther; 2011 Jun; 36(3):348-55. PubMed ID: 21545614
[TBL] [Abstract][Full Text] [Related]
29. Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs).
Viktil KK; Blix HS; Moger TA; Reikvam A
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):667-74. PubMed ID: 16598835
[TBL] [Abstract][Full Text] [Related]
30. Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study.
Szilvay A; Somogyi O; Meskó A; Zelkó R; Hankó B
BMC Health Serv Res; 2019 May; 19(1):282. PubMed ID: 31053135
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD.
Desrochers JF; Lemieux JP; Morin-Bélanger C; Paradis FS; Lord A; Bell R; Berbiche D; Bárcena PQ; Séguin NC; Desforges K; Legris MÈ; Sauvé P; Lalonde L
Am J Kidney Dis; 2011 Oct; 58(4):527-35. PubMed ID: 21778005
[TBL] [Abstract][Full Text] [Related]
32. Factors related to pharmacists' care of migraineurs.
Desselle SP; Skomo ML
Res Social Adm Pharm; 2010 Sep; 6(3):232-45. PubMed ID: 20813336
[TBL] [Abstract][Full Text] [Related]
33. Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation.
Hines LE; Saverno KR; Warholak TL; Taylor A; Grizzle AJ; Murphy JE; Malone DC
Res Social Adm Pharm; 2011 Dec; 7(4):359-68. PubMed ID: 21530417
[TBL] [Abstract][Full Text] [Related]
34. Student Pharmacists' Attitudes Toward Suicide and the Perceived Role of Community Pharmacists in Suicidal Ideation Assessment.
Mospan CM; Gillette C
Am J Pharm Educ; 2020 May; 84(5):7588. PubMed ID: 32577030
[No Abstract] [Full Text] [Related]
35. Reporting natural health product related adverse drug reactions: is it the pharmacist's responsibility?
Walji R; Boon H; Barnes J; Welsh S; Austin Z; Baker GR
Int J Pharm Pract; 2011 Dec; 19(6):383-91. PubMed ID: 22060233
[TBL] [Abstract][Full Text] [Related]
36. Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.
Desmaele S; De Wulf I; Dupont AG; Steurbaut S
Int J Clin Pharm; 2015 Aug; 37(4):656-68. PubMed ID: 25822042
[TBL] [Abstract][Full Text] [Related]
37. Adapting the US Institute for Safe Medication Practices' Medication Safety Self Assessment tool for community pharmacies in Finland.
Teinilä T; Halmepuro-Jaatinen S; Yritys K; Manni K; Airaksinen M
Int J Pharm Pract; 2012 Feb; 20(1):15-24. PubMed ID: 22236176
[TBL] [Abstract][Full Text] [Related]
38. Drug-related problems at discharge: results on the Spanish pharmacy discharge programme CONSULTENOS.
López MP; Saliente MT; Company ES; Monsalve AG; Cueva MA; Domingo EA; Hernández MM; Carrión CC; Martí MC; Querejeta NB; Blasco JB; Milá AR
Int J Pharm Pract; 2010 Oct; 18(5):297-304. PubMed ID: 20840686
[TBL] [Abstract][Full Text] [Related]
39. Assessment of clinical pharmacists' interventions in French hospitals: results of a multicenter study.
Bedouch P; Charpiat B; Conort O; Rose FX; Escofier L; Juste M; Roubille R; Allenet B
Ann Pharmacother; 2008 Jul; 42(7):1095-103. PubMed ID: 18559955
[TBL] [Abstract][Full Text] [Related]
40. Community pharmacists' routine provision of drug-related problem-reduction services.
Al-Taani GM; Ayoub NM
PLoS One; 2022; 17(5):e0267379. PubMed ID: 35507568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
